6. Technological developments for new applications
6.1 Therapeutic proteins and antibodies
The annual market for therapeutic biomolecules is worth over 145 billion dollars. Recombinant monoclonal antibodies are by far the most representative class of therapeutic biomolecules on this market. In the vast majority of cases, they are produced in CHO cells. Despite their ability to produce perfectly assembled and functional monoclonal antibodies
The Ultimate Scientific and Technical Reference
This article is included in
Drugs and pharmaceuticals
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Technological developments for new applications
Conclusion
Bibliography
The Ultimate Scientific and Technical Reference
